Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020
pharmaphorum
AUGUST 24, 2020
The key news to me is the lack of development of approved and late stage anti-angiogenic molecules. 23 rd -24 th November 2020. Snapshot of Alan’s interview: The ophthalmic drugs industry is maturing each year, in your opinion, what are the key developments that have taken place in the last year? Ophthalmic Drugs Conference.
Let's personalize your content